480 Followers on Owler

Oryzon

is a Spain-based biopharmaceutical company that researches and develops epigenetic therapeutics for the treatment of cancer and CNS disorders... Read more
OverviewCompetitorsFundingNews & Insights

Oryzon

is a Spain-based biopharmaceutical company that researches and develops epigenetic therapeutics for the treatment of cancer and CNS disorders... Read more
Oryzon Chairman & CEO: Carlos Buesa

Chairman & CEO

Carlos Buesa

CEO Approval Rating

90/100

2000

Cornella de Llobregat
Barcelona

PublicBME Spanish ExchangesORY

Pharmaceuticals & Biotechnology
BiotechnologyPharmaceuticals
2836 NAICS listing

Annual Revenue
<$1M
Employees
44
Funding
$122.5M

News

Funding
Apr 25, 2025
centralcharts
Oryzon received $34.1M in Post-IPO Equity Funding

Oryzon Competitors

1Minoryx
2ProQR
3GENOMICA S.A.U.
4Regulus
5Valerion Therapeutics
6Alnylam
7Regenxbio
8InteRNA
9Cydan
10Genycell Biotech
Unlock 11 + competitors

Trending Companies